Invokana Linked to Kidney Damage, Diabetic Ketoacidosis
Filed in: Invokana
References
DKA (Ketoacidosis) & Ketones. (2013, August 21). Retrieved May 18, 2016, from http://www.diabetes.org/living-with-diabetes/complications/ketoacidosis-dka.html?referrer=https%3A%2F%2Fwww.google.com%2F
FDA drug safety communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood. (2015, May 5). Retrieved from http://www.fda.gov/Drugs/DrugSafety/ucm446845.htm
"QuarterWatch™ 2015 Quarter 1 And 2 Report: Focus On A New Sleep Medication, Changing Opioid Use, And New Diabetes Medications." Simp.org. Institute for Safe Medication Practices, 14 Jan. 2016. Web. 17 May 2016., Retrieved from https://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=1128
"SGLT2 Inhibitors: A New Class of Diabetes Medications." Diabetes In Control A Free Weekly Diabetes Newsletter for Medical Professionals. Diabetes in Control, 14 Apr. 2013. Web. 17 May 2016, Retrieved from http://www.diabetesincontrol.com/sglt2-inhibitors-a-new-class-of-diabetes-medications/
Wisse, Brent, MD. "Diabetic Ketoacidosis: MedlinePlus Medical Encyclopedia." U.S National Library of Medicine. U.S. National Library of Medicine, 24 July 2015. Web. 17 May 2016. https://www.nlm.nih.gov/medlineplus/ency/article/000320.htm